Stroke Data Public Reporting
JFK University Medical Center Public Reporting
Stroke Data Public Reporting and Outcome
JFK University Medical Center is one of the leading stroke programs in the Central NJ region. JFKUMC is a state recognized and Joint Commission-certified Comprehensive Stroke Program, which is the highest designation available. The Stroke Program achieves comprehensive status for its high volume, quality measures, progressive stroke therapies that are available 24/7, and clinical trial opportunities. JFKUMC utilizes the services of on-site Vascular Neurologist, Vascular Neurology Fellows, Neurology Residents, or Nurse Practitioners to provide emergent evaluation to avoid delays in treatment.
Clinical Outcomes
JFKUMC publicly reports stroke volume and outcomes according to the Comprehensive Stroke Center requirements. The following data reflects JFKUMC stroke admission for the past 3 years.
Stroke Types |
2018 |
2019 |
2020 |
Ischemic Strokes |
625 |
695 |
685 |
Subarachnoid Hemorrhage |
25 |
32 |
25 |
Intracerebral Hemorrhage |
77 |
93 |
90 |
Overall treatment rates for acute ischemic rates remain low in the United States with approximately 11 percent of all strokes receiving thrombolytic treatment. JFKUMC continues to maintain and achieve higher treatment rates in comparison to the national rates for Joint Commission CSC facilities. Another treatment option for acute ischemic strokes is utilizing mechanical thrombectomy. JFKUMC’s endovascular reperfusion rate utilizing mechanical thrombectomy was 80 percent for 2020.
Ischemic Stroke treatment rate |
2018 |
2019 |
2020 |
Thrombolytic therapy |
11% |
14% |
12% |
Mechanical Thrombectomy |
74% |
86% |
80% |
Stroke Prevention
Strokes often occur as the result of a blockage in one of the carotid arteries. In order to prevent a stroke caused by a blocked artery, patients may undergo a procedure to remove the blockage either by carotid artery stenting or carotid endarterectomy. JFKUMC complication rates are superior to the national benchmarks.
Procedure complication rate |
2018 |
2019 |
2020 |
Benchmark |
Endovascular diagnostic angiograms |
0% |
0% |
0% |
1% |
Endovascular Carotid Stenting |
0% |
0% |
0% |
<6% |
Carotid Endarterectomy |
0% |
0% |
0% |
<6% |
Jersey Shore University Medical Center Public Reporting
Jersey Shore University Medical Center is a state-recognized and Joint Commission-certified Comprehensive Stroke program, the highest designation available. JSUMC also achieved the highest recognition for quality and speed, Get With The Guidelines®‒Stroke Gold Plus Achievement Award with Target: Stroke Honor Roll Elite and Target: Type 2 Diabetes Honor Roll. The award recognizes 85 percent or higher adherence to quality indicators for two or more years, and measures to increase the speed of administering clot-busting tPA.
Clinical Outcomes
A Stroke Program achieves comprehensive status for its high volume, quality measures, and progressive stroke therapies that are available 24/7. Our stroke volume and outcomes data are publicly reported according to Comprehensive Stroke Center requirements. This data reflects stroke admissions to Jersey Shore University Medical Center.
JERSEY SHORE UNIVERSITY MEDICAL CENTER VOLUMES
Stroke Types |
2019 |
2020 |
Ischemic Strokes |
529 |
530 |
Intracerebral Hemorrhage |
109 |
128 |
Subarachnoid Hemorrhage |
43 |
50 |
Treatment rates for acute ischemic stroke remain low in the United States. Approximately, 11% percent of all strokes receive treatment utilizing IV Alteplase.
Ischemic Stroke Treatment Rate |
2019 |
2020 |
National Average |
Alteplase (tPA); |
20% |
17.5% |
11.8% |
Mechanical Thrombectomy(109) |
20.6% |
20.7% |
8% |
Often strokes occur as the result of a blockage in one of the carotid arteries (two main arteries in the neck that supply blood to the brain). In order to prevent a stroke caused by a blocked artery, patients may undergo a procedure to remove the blockage, either carotid artery stenting or carotid endarterectomy. JSUMC complication rates are superior to the national benchmark.
Surgical Complication Rate |
2019 |
2020 |
Benchmark |
Endovascular Angiograms |
0% |
1% |
1% |
Carotid Interventions |
1.6% |
1.4% |
<6% |
Hackensack University Medical Center Public Reporting
Hackensack University Medical Center (HUMC) is a state-recognized and Joint Commission Certified Comprehensive Stroke program, the highest designation available. HUMC also achieved the highest recognition for quality and speed, Get With The Guidelines®‒Stroke Gold Plus Achievement Award with Target: Stroke Honor Roll Elite and Target: Type 2 Diabetes Honor Roll. The award recognizes 85 percent or higher adherence to quality indicators for two or more years, and measures to increase the speed of administering clot-busting tPA.
Clinical Outcomes
A Stroke Program achieves comprehensive status for its high volume, quality measures, and progressive stroke therapies that are available 24/7. Our stroke volume and outcomes data are publicly reported according to Comprehensive Stroke Center requirements. This data reflects stroke admissions to Hackensack University Medical Center.
HACKENSACK UNIVERSITY MEDICAL CENTER VOLUMES
Stroke Types |
2019 |
2020 |
Ischemic Strokes |
589 |
501 |
Intracerebral Hemorrhage |
122 |
91 |
Subarachnoid Hemorrhage |
59 |
49 |
Treatment rates for acute ischemic stroke remain low in the United States. Approximately, 11 percent of all strokes receive treatment utilizing IV Alteplase.
Ischemic Stroke Treatment Rate |
2019 |
2020 |
National Average |
Alteplase (tPA) |
13% |
15% |
11.8% |
Mechanical Thrombectomy |
14% |
13% |
8% |
Stroke Prevention
Often strokes occur as the result of a blockage in one of the carotid arteries (two main arteries in the neck that supply blood to the brain). In order to prevent a stroke caused by a blocked artery, patients may undergo a procedure to remove the blockage, either carotid artery stenting or carotid endarterectomy. HUMC complication rates are superior to the national benchmark.
Surgical Complication Rate |
2019 |
2020 |
Benchmark |
Endovascular Angiograms |
0% |
0% |
1% |
Carotid Interventions |
2.6% |
1.9% |
<6% |